Quizartinib Doubles Overall Survival in FLT3-ITD-Positive AML Quizartinib Doubles Overall Survival in FLT3-ITD-Positive AML
The FLT3 inhibitor, taken during chemotherapy and continued as a single agent for up to 3 years, significantly improved survival compared with standard chemotherapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 13, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

People Under 50 With Obesity May Need More CRC Prevention People Under 50 With Obesity May Need More CRC Prevention
Metabolic syndrome is positively linked with colorectal cancer before age 50 at similar rates to that of people who receive a diagnosis after age 50.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 13, 2022 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news

Exercise Reduced Risk of Frailty Fractures in Cancer Survivors Exercise Reduced Risk of Frailty Fractures in Cancer Survivors
Patients with cancer who met physical activity guidelines 5 years after diagnosis had a 12% reduced risk for fractures.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 10, 2022 Category: Cancer & Oncology Tags: Orthopaedics News Source Type: news

GI Oncology at ASCO 2022: Tumor Sidedness, ctDNA, and MRD GI Oncology at ASCO 2022: Tumor Sidedness, ctDNA, and MRD
John Marshall and Mark Lewis discuss the biggest advances in GI oncology at ASCO 2022: tumor sidedness, circulating tumor DNA, and minimal residual disease.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 10, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

New Advances Transform Treatment of Prostate Cancer New Advances Transform Treatment of Prostate Cancer
A urologist describes improvements in imaging, the importance of genetics, and progress toward personalized treatment of prostate cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 10, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Exercise Slows Tumor Growth in Pancreatic Cancer Exercise Slows Tumor Growth in Pancreatic Cancer
Aerobic exercise slows pancreatic cancer growth in animal models and prolongs survival in both animals and patients, especially when combined with anti-PD1 drugs.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 9, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

US Spends Most on Cancer Care, but Does Not Have Lowest Mortality US Spends Most on Cancer Care, but Does Not Have Lowest Mortality
Even though the United States spends twice as much on cancer care as other high-income countries, cancer mortality rates are only marginally better than average.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 9, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' Underwhelming' Improvements in mCRC Overall Survival'Underwhelming' Improvements in mCRC Overall Survival
Overall survival for patients with metastatic colorectal cancer has improved over recent decades with the introduction of novel systemic therapies, but the gains have been modest at best, say experts.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 9, 2022 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news

No CVD Issues Apparent Years After Aromatase Inhibitor Therapy No CVD Issues Apparent Years After Aromatase Inhibitor Therapy
The findings in breast cancer survivors are ' reassuring, ' given the benefit of aromatase inhibitors, the authors say. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 9, 2022 Category: Cancer & Oncology Tags: Ob/Gyn & Women ' s Health News Source Type: news

Obesity Heightens Chemotherapy Toxicity in Breast Cancer Obesity Heightens Chemotherapy Toxicity in Breast Cancer
Obesity signals the need for greater monitoring of adverse events during chemotherapy. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 9, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Acetaminophen Linked to Diminished Response to Immunotherapy in Cancer Acetaminophen Linked to Diminished Response to Immunotherapy in Cancer
The commonly used pain killer was strongly associated with a diminished response to immune checkpoint inhibitors in a study of 600 patients with cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 8, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

High Risk for Persistent Opioid Use in Young People With Sarcoma High Risk for Persistent Opioid Use in Young People With Sarcoma
Roughly one quarter of adolescents and young adults with sarcoma will continue to use opioids after their cancer treatment, a new study shows.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 8, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Triple Therapy May Reduce the Risk for Tumors in the Elderly Triple Therapy May Reduce the Risk for Tumors in the Elderly
A combination of high-dose vitamin D, omega-3 fatty acids, and a simple at-home training program reduces the risk of cancer by 61% in healthy people over age 70 years, data indicate.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 7, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Pseudocirrhosis in Breast Cancer May Signal Liver Metastases Pseudocirrhosis in Breast Cancer May Signal Liver Metastases
A large case series of metastatic breast cancer patients with pseudocirrhosis found that almost all such patients had hormone receptor –positive disease as well as extensive liver metastases.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 7, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Do Minority Patients Receive the Same Quality of Cancer Care? Do Minority Patients Receive the Same Quality of Cancer Care?
Learn about the sociodemographic, economic, and research factors that contribute to disparities in cancer care, and how physicians can help reduce these differences.Medscape Blogs (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 7, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Blog Source Type: news